Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abvc Biopharma (ABVC) Return on Equity (2016 - 2025)

Abvc Biopharma (ABVC) has disclosed Return on Equity for 12 consecutive years, with 0.65% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Equity rose 345.0% year-over-year to 0.65%, compared with a TTM value of 0.65% through Dec 2025, up 345.0%, and an annual FY2025 reading of 1.36%, up 288.0% over the prior year.
  • Return on Equity was 0.65% for Q4 2025 at Abvc Biopharma, down from 0.5% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.5% in Q3 2025 and bottomed at 9.22% in Q2 2021.
  • Average Return on Equity over 5 years is 3.36%, with a median of 2.5% recorded in 2022.
  • Peak annual rise in Return on Equity hit 1295bps in 2021, while the deepest fall reached -1376bps in 2021.
  • Year by year, Return on Equity stood at 1.46% in 2021, then plummeted by -150bps to 3.65% in 2022, then soared by 57bps to 1.58% in 2023, then plummeted by -159bps to 4.1% in 2024, then skyrocketed by 84bps to 0.65% in 2025.
  • Business Quant data shows Return on Equity for ABVC at 0.65% in Q4 2025, 0.5% in Q3 2025, and 0.52% in Q2 2025.